신경외과용 디바이스 : 시장 인사이트, 경쟁 구도 및 시장 예측(2034년)

Neurosurgery Devices Market Summary

Overview:

• The global neurosurgery devices market was valued at USD 14.50 billion in 2025 and is projected to reach USD 45.32 billion by 2034.
• The market is expected to expand at a CAGR of 13.5% during the forecast period 2026-2034, supported by the rising prevalence of brain tumors and neurological disorders, the shift toward minimally invasive and image-guided neurosurgery, advances in surgical robotics and stereotactic guidance, and continuous technological innovation across the neurosurgical device portfolio.
• By product type, the neurosurgical navigation systems segment dominated the neurosurgery devices market with a 22% share in 2025.
• By application, the brain tumor surgery segment dominated the neurosurgery devices market with a 30% share in 2025.
• By end-user, the hospitals segment dominated the neurosurgery devices market with a 78% share in 2025.
• North America accounted for the largest share of the neurosurgery devices market at 38% in 2025, while Asia-Pacific is anticipated to register the fastest growth through 2034.

Neurosurgery devices are the instruments, implants, and capital systems used to diagnose, access, treat, and monitor disorders of the brain, spine, and peripheral nervous system, spanning the tools that plan and guide a neurosurgical procedure, the instruments that perform it, and the implants and materials that repair and manage its consequences. The market is organized by the product supplied, the surgical application, and the setting of care, and the product structure adopted in this report follows the way the leading manufacturers organize their neurosurgery portfolios. Platform technologies include neurosurgical navigation systems that locate anatomy in real time, intraoperative imaging systems, and the stereotactic and robotic guidance systems that position instruments along a planned trajectory. Powered instruments, principally the high-speed surgical drills used to open and shape bone, and neuroendoscopes for endoscopic and skull-base approaches, perform the access and resection. Ultrasonic aspiration systems remove tumor tissue, aneurysm and neurovascular clips occlude vascular lesions, and laser interstitial thermal therapy systems ablate lesions under image guidance. Cerebrospinal fluid management devices, comprising shunts, programmable valves, and external drainage, treat hydrocephalus and manage intracranial pressure; neuromonitoring and intracranial pressure devices track the injured or operated brain; dural repair and sealant devices restore the dura, and cranial stabilization and fixation devices immobilize the head and reconstruct the skull. The contemporary market is defined by the migration toward minimally invasive and image-guided surgery, the rapid advance of cranial robotics, and the integration of artificial intelligence into surgical planning and navigation.

Neurosurgery Devices Market Key Growth Drivers

• The rising global prevalence of brain tumors and neurological disorders, with the National Brain Tumor Society reporting that some 700,000 people in the United States are living with a brain tumor, sustaining demand for tumor resection and related devices.
• The aging of the population, which increases the incidence of brain tumors, cerebrovascular disease, normal pressure hydrocephalus, and the degenerative conditions that require neurosurgical intervention.
• The shift toward minimally invasive and image-guided neurosurgery, in which navigation, endoscopy, and tubular access reduce the length of hospital stay and the risk of complications relative to open craniotomy.
• The rapid advance of surgical robotics and stereotactic guidance, exemplified by cranial robotic platforms that position instruments for biopsy, electrode placement, and laser ablation with high accuracy.
• Continuous technological innovation across the portfolio, including intraoperative imaging, laser interstitial thermal therapy, ultrasonic aspiration, and the integration of artificial intelligence and tractography into surgical planning.
• Rising neurosurgical procedure volumes across tumor resection, hydrocephalus management, epilepsy and functional surgery, and neurotrauma, driven by improving diagnosis and expanding access.
• Increasing healthcare investment and the expansion of neurosurgical capacity across emerging markets, which convert a historically underserved burden into treated procedures.

Key Companies in Neurosurgery Devices Market

The competitive landscape is led by the following active manufacturers:

• Medtronic plc
• Stryker Corporation
• Integra LifeSciences Holdings Corporation
• B. Braun SE (Aesculap)
• Johnson & Johnson MedTech (DePuy Synthes)
• Zimmer Biomet Holdings Inc.
• Brainlab AG
• KARL STORZ SE & Co. KG
• Elekta AB
• Globus Medical Inc.

Factors Contributing to the Growth of the Neurosurgery Devices Market

Market Drivers

Rising Prevalence of Brain Tumors and Neurological Disorders

The foundational driver of the neurosurgery devices market is the rising global prevalence of brain tumors and neurological disorders, which generates the procedural volume upon which the entire category depends. Brain and other central nervous system tumors, cerebrovascular disease, hydrocephalus, epilepsy, movement disorders, and neurotrauma together produce a large and growing population requiring neurosurgical intervention, and the National Brain Tumor Society reports that some 700,000 people in the United States are living with a brain tumor, of which the meningiomas and gliomas that dominate adult malignant disease drive a substantial share of tumor resection procedures. The burden is rising as diagnosis improves, as imaging detects lesions earlier and more often, and as the population ages into the decades of peak incidence, and each diagnosed lesion that proceeds to surgery draws upon the navigation, imaging, powered instruments, ultrasonic aspiration, and dural repair devices that constitute the market. The chronic and progressive nature of many neurological conditions means that the need is durable rather than episodic, and the expansion of neurosurgical capability into conditions previously managed medically further enlarges the addressable population. Because the disease burden is large, rising, and concentrated in exactly the procedures that consume the highest-value neurosurgical devices, it provides the most durable foundation for market growth.

Aging Population and Rising Incidence of Age-Related Neurosurgical Disease

Demographic aging is a powerful structural driver of the neurosurgery devices market, because the conditions that neurosurgery treats are concentrated in older adults and because the aging of the population across the developed and increasingly the developing world expands the at-risk pool year on year. The incidence of brain tumors, of the cerebrovascular disease that produces aneurysms and hemorrhage, of normal pressure hydrocephalus, and of the degenerative spinal and functional conditions that require neurosurgical intervention all rise with age, so the steady increase in the number and proportion of older adults translates directly into rising neurosurgical demand. Older patients also benefit particularly from the minimally invasive and image-guided approaches that reduce the physiological burden of surgery, since the risks of prolonged anesthesia and open craniotomy are greater in this group, which strengthens the clinical case for the advanced navigation, endoscopy, and robotic devices that enable less invasive intervention. Normal pressure hydrocephalus, a condition of the elderly treated by cerebrospinal fluid shunting, exemplifies the direct link between aging and device demand, as does the rising incidence of chronic subdural hematoma. Because these demographic trends are slow, predictable, and effectively irreversible, and because they concentrate disease in the population increasingly offered intervention, aging provides an unusually stable foundation for long-term growth.

Market Restraints

Despite a rising disease burden and rapid technological advances, the neurosurgery devices market faces several material constraints. The most significant is the high cost of the advanced capital systems, since navigation, intraoperative imaging, and robotic platforms represent substantial capital investments that many hospitals, and particularly those in emerging markets and smaller centers, find difficult to justify, and this cost barrier restricts the adoption of the very technologies that define modern neurosurgery. Reimbursement constraints compound the cost barrier, since the coverage and payment available for advanced neurosurgical procedures and the devices they require vary across jurisdictions and payers and can make it financially unviable for a center to adopt a new and expensive technology even where the clinical case is strong. A third and fundamental constraint is the shortage of trained neurosurgeons and the steep learning curve associated with advanced devices, since the sophisticated navigation, endoscopic, and robotic systems that the market supplies depend upon skilled surgeons and operating room teams whose availability is uneven and whose training in new technology takes time, and inadequate access to this expertise limits both the safe adoption of advanced devices and the achievement of the outcomes that justify their cost. The complexity and risk of neurosurgical procedures themselves impose a constraint, since the consequences of error are severe and the adoption of a new device or technique is appropriately cautious. Additional constraints include the stringent and lengthy regulatory pathways governing implantable and capital neurosurgical devices, which raise development cost and delay market entry; the limited neurosurgical and rehabilitation infrastructure across much of the world, which leaves a large share of the population unable to access even basic neurosurgical care; and the long capital replacement cycles that slow the diffusion of new platform technology. Together these cost, reimbursement, workforce, regulatory, and infrastructure factors ensure that growth, while robust, proceeds against genuine constraint.

Neurosurgery Devices Market Segment Analysis

The global neurosurgery devices market by product type (neurosurgical navigation systems, intraoperative imaging systems, stereotactic and robotic guidance systems, neurosurgical powered instruments, neuroendoscopes, ultrasonic aspiration systems, aneurysm and neurovascular clips, cerebrospinal fluid management devices, neuromonitoring and intracranial pressure devices, dural repair and sealant devices, cranial stabilization and fixation devices, laser interstitial thermal therapy systems, and neurosurgical hand instruments and accessories), by application (brain tumor surgery, cerebrovascular surgery, hydrocephalus and cerebrospinal fluid management, functional neurosurgery, neurotrauma, spinal neurosurgery, and others), by end-user (hospitals, ambulatory surgical centers, and specialty neurosurgery and academic centers), and by geography (North America, Europe, Asia-Pacific, and the Rest of the World).

By Product Type

Dominant Subsegment: Neurosurgical Navigation Systems.

The neurosurgical navigation systems segment accounted for a 22% share of the neurosurgery devices market in 2025. Neurosurgical navigation systems dominate the product-type structure because image-guided surgery has become the anchor of the modern neurosurgical suite and because the navigation platform is the high-value system upon which the powered instruments, imaging, and robotics of a procedure are organized. A navigation system precisely locates anatomical structures in open and minimally invasive cranial and spinal procedures, allowing the surgeon to relate the operative field to preoperative and intraoperative imaging and to protect eloquent brain and vascular structures during resection, and it has become the standard of care for a widening range of cranial procedures. The leading manufacturers position navigation as the platform of their neurosurgery portfolios, integrating it with powered drills, imaging, and robotic guidance into unified surgical ecosystems, and the capital value, the associated disposables, and the service revenue together make navigation the largest single product category. Cerebrospinal fluid management devices constitute a substantial category by volume, encompassing the shunts, programmable valves, and external drainage used in the very common treatment of hydrocephalus, and neurosurgical powered instruments, principally the high-speed surgical drills used in essentially every cranial and spinal procedure, form another large category. Stereotactic and robotic guidance systems are the fastest-growing category, while ultrasonic aspiration, aneurysm clips, neuroendoscopes, laser ablation, dural repair, neuromonitoring, cranial stabilization, and hand instruments complete the structure. Neurosurgical navigation systems are expected to retain their leading share throughout the forecast period.

By Application

Dominant Subsegment: Brain Tumor Surgery.

The brain tumor surgery segment accounted for a 30% share of the neurosurgery devices market in 2025. Brain tumor surgery dominates the application structure because tumor resection is the highest-value neurosurgical procedure by device intensity, drawing upon the widest range of advanced devices in the portfolio, and because the large and rising population of brain tumor patients sustains a substantial and growing procedure volume. The resection of a brain tumor engages navigation to localize the lesion and protect function, intraoperative imaging to confirm the extent of resection, powered instruments to open the skull, ultrasonic aspiration to remove the tumor while sparing adjacent tissue, dural repair and sealants to close, and increasingly laser interstitial thermal therapy to ablate deep or inoperable lesions and robotic guidance to place biopsy needles and ablation catheters, so a single tumor case consumes more high-value device content than almost any other neurosurgical procedure. The National Brain Tumor Society reports that some 700,000 people in the United States are living with a brain tumor, and the meningiomas and gliomas that dominate adult disease drive a large and durable resection volume. Cerebrovascular surgery, encompassing the clipping of aneurysms and the treatment of vascular malformations, constitutes a substantial second application, and hydrocephalus and cerebrospinal fluid management, functional neurosurgery for epilepsy and movement disorders, neurotrauma, and spinal neurosurgery complete the structure. Brain tumor surgery is expected to retain its leading share throughout the forecast period.

Neurosurgery Devices Market Region Analysis

Dominant Region: North America

North America accounted for a 38% share of the global neurosurgery devices market in 2025. The region is expected to account for the largest share of the global market, supported by advanced healthcare infrastructure, high healthcare expenditure, extensive research and development activity, and the presence and headquarters of many of the leading neurosurgery device manufacturers. The United States hosts the largest concentration of neurosurgical capacity in the world, with a high density of academic medical centers and specialized neuroscience institutes that perform the highest procedure volumes and are the earliest adopters of advanced navigation, imaging, and robotic systems, and the strong reimbursement environment for complex neurosurgical procedures supports the adoption of premium technology. The concentration of manufacturer research and development and commercial operations in the region, exemplified by the leading navigation, robotics, and implant portfolios headquartered or principally operated in North America, ensures early access to innovation and deep clinical and technical support, and the region leads in the regulatory clearance and early commercialization of new neurosurgical technologies. The rising prevalence of brain tumors and neurological disease, the aging population, and the high adoption of minimally invasive and image-guided surgery reinforce the position of the region. The region is expected to retain its leading position throughout the forecast period.

Fastest Growing Region: Asia-Pacific

Asia-Pacific is projected to register the fastest compound annual growth rate in the neurosurgery devices market through 2034. The region is emerging as the principal growth engine of the market, propelled by very large populations, a rising burden of brain tumors, cerebrovascular disease, trauma, and hydrocephalus, expanding healthcare infrastructure, and increasing investment in neurosurgical capacity across China, Japan, India, and South Korea. The region combines the largest populations in the world with a historically underserved neurosurgical burden, and the expansion of neurosurgical capacity, including the building and equipping of neurosurgical centers, the training of neurosurgeons, and the acquisition of navigation, imaging, endoscopy, and robotic systems, is converting a large unmet need into demand. Governments and private providers are investing heavily in advanced healthcare infrastructure, and the rising incidence of the conditions that neurosurgery treats, driven by aging and by the epidemiological transition, creates rapidly growing demand. China combines a very large population with a rapidly developing domestic medical device industry and growing neurosurgical capacity, Japan combines an aged population with sophisticated neurosurgical and robotics capability, and India combines a very large population with a rapidly expanding private neurosurgical sector. The coexistence of demand for premium and cost-effective devices creates opportunity for international and regional manufacturers alike. Regional growth is expected to exceed the global average across every segment.

Regional Commentary

North America

North America leads on value and innovation, holding a 38% share in 2025. The region combines advanced healthcare infrastructure, high expenditure, and strong reimbursement for complex neurosurgery with a high density of academic and specialized neuroscience centers and the headquarters and principal operations of many leading manufacturers. High adoption of minimally invasive and image-guided surgery, early access to robotic and navigation innovation, and the rising burden of brain tumors and neurological disease reinforce the position of the region. Near-term dynamics are shaped by the advance of cranial robotics, the integration of artificial intelligence and tractography into navigation, laser interstitial thermal therapy, and the extension of unified planning, navigation, and robotics platforms into cranial procedures.

Europe

Europe is a large and sophisticated market, home to several of the leading neurosurgery device manufacturers, including major navigation, robotics, endoscopy, aneurysm clip, and cerebrospinal fluid device companies, and supported by well-developed healthcare systems, strong academic neurosurgery, and established clinical pathways, with Germany, France, and the United Kingdom the principal markets. The region hosts distinctive manufacturer strengths, including the German and European leadership in aneurysm clips, neuroendoscopy, and programmable cerebrospinal fluid valves, and it combines a substantial and aging patient population with generally supportive public healthcare and high adoption of advanced devices. Reimbursement varies by country, and public budget constraints temper the pace of capital adoption, but the region sustains a competitive market served by both global and specialized regional participants.

Asia-Pacific

Asia-Pacific is the fastest-growing region, propelled by very large populations, a rising burden of brain tumors, cerebrovascular disease, trauma, and hydrocephalus, expanding healthcare infrastructure, and increasing investment in neurosurgical capacity across China, Japan, India, and South Korea. The expansion of neurosurgical centers, the training of surgeons, and the acquisition of navigation, imaging, endoscopy, and robotic systems are converting a historically underserved burden into demand. China combines a very large population with a developing domestic device industry, Japan combines an aged population with advanced robotics capability, and India combines a very large population with a rapidly expanding private sector. Growth exceeds the global average across every segment.

Rest of World

The Rest of the World comprises the Middle East, Africa, and South America. Access is highly stratified. The Gulf states have invested substantially in advanced neurosurgical and neuroscience capacity, and the larger Latin American markets, particularly Brazil, support established neurosurgical programs and growing device adoption, together representing steady growth. Much of Africa faces severe constraints in neurosurgical infrastructure and in the trained neurosurgeons required, so a large share of the neurosurgical burden is never treated, and the World Health Organization has emphasized the substantial global gap between the need for neurosurgical care and its availability. Regional growth will be driven by investment in neurosurgical infrastructure, the training of surgeons, the rising burden of trauma, tumors, and cerebrovascular disease, and the availability of cost-appropriate devices from regional and international manufacturers.

Neurosurgery Devices Market Competitive Landscape

The global neurosurgery devices market is classified as Moderately Concentrated. The market is led by a small group of large medical technology companies with broad neurosurgery portfolios spanning navigation, imaging, robotics, powered instruments, and implants, which hold a substantial combined share, complemented by specialized manufacturers of neuroendoscopes, aneurysm clips, laser ablation systems, cerebrospinal fluid devices, and cranial robotics. Competition centers upon the breadth and integration of the neurosurgery portfolio, the sophistication of navigation and robotics, the depth of the implant and disposables franchise, clinical evidence and surgeon training, and increasingly upon artificial intelligence and unified surgical ecosystems. The competitive landscape is evaluated across the following dimensions:

• Market concentration: Moderately concentrated, with a small group of large diversified manufacturers holding a substantial combined share across the platform and implant categories alongside specialized companies in endoscopy, aneurysm clips, laser ablation, cerebrospinal fluid devices, and robotics, and with the scale, portfolio breadth, and capital and clinical support of the leaders constituting a barrier to entry.
• Leading players: Medtronic leads with the broadest neurosurgery portfolio spanning navigation, imaging, robotics, powered instruments, cerebrospinal fluid management, and laser ablation, with Stryker and Integra LifeSciences strong across navigation, powered instruments, ultrasonic aspiration, dural repair, cerebrospinal fluid, and cranial stabilization, B. Braun through Aesculap in aneurysm clips, endoscopy, instruments, and shunts, and Johnson & Johnson MedTech, Zimmer Biomet, Brainlab, KARL STORZ, Elekta, and Globus Medical strong in defined platform and robotic segments.
• Geographic reach: The leading participants maintain global commercial, clinical, and service organizations, which are decisive because navigation, imaging, and robotic systems require local installation, training, and service, while specialized European manufacturers lead in aneurysm clips, endoscopy, and cerebrospinal fluid valves, and regional manufacturers serve domestic and cost-sensitive markets, particularly across Asia-Pacific.
• Product portfolio strength: Competitive advantage rests upon offering an integrated neurosurgery ecosystem spanning planning, navigation, imaging, powered instruments, robotics, and the implants and disposables consumed in each procedure, since surgeons and hospitals value a unified and supported workflow from a single accountable supplier, though specialized manufacturers compete effectively through a single superior device such as an aneurysm clip, endoscope, or laser ablation system.
• Pipeline strength: Development is concentrated in cranial robotics and stereotactic guidance, artificial-intelligence-enabled planning and navigation including tractography, unified planning, navigation, and robotics platforms, laser interstitial thermal therapy, next-generation intraoperative imaging, and the integration of brain-computer interface and mapping technologies with surgical navigation.
• Strategic partnerships: Collaboration spans the integration of surgical navigation with imaging and robotic systems, partnerships with imaging companies for intraoperative imaging, and alliances with emerging technology developers, exemplified by the partnership to integrate a cortical brain-computer interface with a surgical navigation platform, extending the reach of the neurosurgical ecosystem.
• M&A activity: Acquisition is a defining dynamic through which the diversified leaders assemble integrated neurosurgery portfolios and acquire specialized technologies, exemplified by the consolidation of a major specialty surgical franchise combining dural repair, cerebrospinal fluid, neurocritical care, ultrasonic surgery, and cranial stabilization, and by the continued acquisition of robotics, laser ablation, and navigation capability.
• Innovation focus: Innovation is shifting toward cranial robotics, artificial intelligence and tractography in planning and navigation, unified surgical ecosystems connecting planning, navigation, imaging, and robotics, minimally invasive and endoscopic approaches, laser interstitial thermal therapy, and the integration of mapping and brain-computer interface technologies with neurosurgical platforms.
• Regulatory standing: Regulatory clearance and approval for implantable and capital neurosurgical devices in the major jurisdictions is a decisive credential, and the stringent and lengthy pathways governing these devices both raise the barrier to entry and reward the scale and regulatory capability of the leading manufacturers, while the safety-critical nature of neurosurgical devices makes demonstrated clinical evidence essential to adoption.

Neurosurgery Devices Market Recent Developmental Activities

In March 2026, Medtronic expanded the United States Food and Drug Administration clearance of its Stealth AXiS surgical system from spine into cranial and ENT procedures, unifying planning, navigation, and robotics on one platform and adding artificial-intelligence-based tractography and integrated intraoperative imaging. Strategic significance: extending a unified planning, navigation, and robotics platform into cranial procedures advanced the convergence toward integrated surgical ecosystems and brought artificial-intelligence-based tractography, which maps the white-matter tracts a surgeon must avoid, into the cranial navigation workflow of the market leader.

Neurosurgery Devices Market Segmentation

Neurosurgery Devices Market Assessment by Product Type

• Neurosurgical Navigation Systems
• Intraoperative Imaging Systems
• Stereotactic and Robotic Guidance Systems
• Neurosurgical Powered Instruments
• Neuroendoscopes
• Ultrasonic Aspiration Systems
• Aneurysm and Neurovascular Clips
• Cerebrospinal Fluid Management Devices
• Neuromonitoring and Intracranial Pressure Devices
• Dural Repair and Sealant Devices
• Cranial Stabilization and Fixation Devices
• Laser Interstitial Thermal Therapy Systems
• Neurosurgical Hand Instruments and Accessories

Neurosurgery Devices Market Assessment by Application

• Brain Tumor Surgery
• Cerebrovascular Surgery
• Hydrocephalus and Cerebrospinal Fluid Management
• Functional Neurosurgery
• Neurotrauma
• Spinal Neurosurgery
• Others

Neurosurgery Devices Market Assessment by End-User

• Hospitals
• Ambulatory Surgical Centers
• Specialty Neurosurgery and Academic Centers

Neurosurgery Devices Market Assessment by Geography

• North America
• United States Neurosurgery Devices Market Size in USD million (2023-2034)
• Canada Neurosurgery Devices Market Size in USD million (2023-2034)
• Mexico Neurosurgery Devices Market Size in USD million (2023-2034)
• Europe
• France Neurosurgery Devices Market Size in USD million (2023-2034)
• Germany Neurosurgery Devices Market Size in USD million (2023-2034)
• United Kingdom Neurosurgery Devices Market Size in USD million (2023-2034)
• Italy Neurosurgery Devices Market Size in USD million (2023-2034)
• Spain Neurosurgery Devices Market Size in USD million (2023-2034)
• Rest of Europe Neurosurgery Devices Market Size in USD million (2023-2034)
• Asia-Pacific
• China Neurosurgery Devices Market Size in USD million (2023-2034)
• Japan Neurosurgery Devices Market Size in USD million (2023-2034)
• India Neurosurgery Devices Market Size in USD million (2023-2034)
• Australia Neurosurgery Devices Market Size in USD million (2023-2034)
• South Korea Neurosurgery Devices Market Size in USD million (2023-2034)
• Rest of Asia-Pacific Neurosurgery Devices Market Size in USD million (2023-2034)
• Rest of the World
• Middle East Neurosurgery Devices Market Size in USD million (2023-2034)
• Africa Neurosurgery Devices Market Size in USD million (2023-2034)
• South America Neurosurgery Devices Market Size in USD million (2023-2034)

Frequently Asked Questions:

Q1. At what rate is the neurosurgery devices market expected to grow?

The global neurosurgery devices market is projected to grow at a compound annual growth rate of 13.5% during the forecast period from 2026 to 2034.

Q2. What is the current and projected size of the neurosurgery devices market?

On a DelveInsight-modeled basis, the global neurosurgery devices market was valued at USD 14.50 billion in 2025 and is projected to reach USD 45.32 billion by 2034.

Q3. Which region dominates the neurosurgery devices market?

North America dominated the neurosurgery devices market with a 38% share in 2025 on a modeled basis, supported by advanced healthcare infrastructure, high healthcare expenditure, strong reimbursement for complex neurosurgery, a high density of academic and specialized neuroscience centers, and the presence and headquarters of many of the leading manufacturers. Asia-Pacific is projected to record the fastest compound annual growth rate through 2034, driven by very large populations, a rising burden of brain tumors, cerebrovascular disease, trauma, and hydrocephalus, and expanding neurosurgical capacity across China, Japan, India, and South Korea.

Q4. What are the key factors driving growth in the neurosurgery devices market?

The principal drivers are the rising prevalence of brain tumors and neurological disorders, with the National Brain Tumor Society reporting some 700,000 people living with a brain tumor in the United States; the aging of the population, which increases the incidence of tumors, cerebrovascular disease, and hydrocephalus; the shift toward minimally invasive and image-guided neurosurgery; the rapid advance of surgical robotics and stereotactic guidance; continuous technological innovation including laser ablation, intraoperative imaging, and artificial intelligence in planning and navigation; rising neurosurgical procedure volumes; and expanding access and investment in emerging markets.

Q5. Who are the major players in the neurosurgery devices market?

The market is moderately concentrated and led by Medtronic plc, which holds the broadest neurosurgery portfolio, alongside Stryker Corporation and Integra LifeSciences Holdings Corporation, which are strong across navigation, powered instruments, ultrasonic aspiration, dural repair, cerebrospinal fluid, and cranial stabilization, and B. Braun SE through Aesculap in aneurysm clips, endoscopy, and shunts. Additional leaders include Johnson & Johnson MedTech (DePuy Synthes), Zimmer Biomet Holdings Inc., Brainlab AG, KARL STORZ SE & Co. KG, Elekta AB, and Globus Medical Inc., alongside Monteris Medical, Renishaw plc, NICO Corporation, Peter Lazic GmbH, and Sophysa Ltd.

Table of Contents

1. Neurosurgery Devices Market Introduction

• 1.1. Scope of the Report
• 1.2. Market Segmentation
• 1.3. Market Overview at a Glance

2. Neurosurgery Devices Market Executive Summary

• 2.1. Key Highlights and Market Snapshot

3. Neurosurgery Devices Market Key Factors Analysis

• 3.1. Market Drivers
  • 3.1.1. Rising Prevalence of Brain Tumors and Neurological Disorders
  • 3.1.2. Aging Population and Age-Related Neurosurgical Disease
  • 3.1.3. Shift Toward Minimally Invasive and Image-Guided Neurosurgery
  • 3.1.4. Advances in Surgical Robotics and Stereotactic Guidance
• 3.2. Market Restraints
  • 3.2.1. High Cost of Advanced Capital Systems
  • 3.2.2. Reimbursement Constraints
  • 3.2.3. Shortage of Trained Neurosurgeons and Learning Curve
• 3.3. Market Opportunities
  • 3.3.1. Cranial Robotics, Artificial Intelligence, and Laser Ablation
  • 3.3.2. Emerging Markets and Expanding Neurosurgical Capacity

4. Impact Analysis: AI, Geopolitical, Trade, and Economic Developments

5. Regulatory Analysis

• 5.1. The United States
• 5.2. Europe
• 5.3. Japan
• 5.4. China

6. Neurosurgery Devices Market Porter's Five Forces Analysis

• 6.1. Bargaining Power of Suppliers
• 6.2. Bargaining Power of Consumers
• 6.3. Threat of New Entrants
• 6.4. Threat of Substitutes
• 6.5. Competitive Rivalry

7. Neurosurgery Devices Market Assessment

• 7.1. By Product Type
  • 7.1.1. Neurosurgical Navigation Systems
  • 7.1.2. Intraoperative Imaging Systems
  • 7.1.3. Stereotactic and Robotic Guidance Systems
  • 7.1.4. Neurosurgical Powered Instruments
  • 7.1.5. Neuroendoscopes
  • 7.1.6. Ultrasonic Aspiration Systems
  • 7.1.7. Aneurysm and Neurovascular Clips
  • 7.1.8. Cerebrospinal Fluid Management Devices
  • 7.1.9. Neuromonitoring and Intracranial Pressure Devices
  • 7.1.10. Dural Repair and Sealant Devices
  • 7.1.11. Cranial Stabilization and Fixation Devices
  • 7.1.12. Laser Interstitial Thermal Therapy Systems
  • 7.1.13. Neurosurgical Hand Instruments and Accessories
• 7.2. By Application
  • 7.2.1. Brain Tumor Surgery
  • 7.2.2. Cerebrovascular Surgery
  • 7.2.3. Hydrocephalus and Cerebrospinal Fluid Management
  • 7.2.4. Functional Neurosurgery
  • 7.2.5. Neurotrauma
  • 7.2.6. Spinal Neurosurgery
  • 7.2.7. Others
• 7.3. By End-User
  • 7.3.1. Hospitals
  • 7.3.2. Ambulatory Surgical Centers
  • 7.3.3. Specialty Neurosurgery and Academic Centers
• 7.4. By Geography
  • 7.4.1. North America
    • 7.4.1.1. United States Neurosurgery Devices Market Size in USD million (2023-2034)
    • 7.4.1.2. Canada Neurosurgery Devices Market Size in USD million (2023-2034)
    • 7.4.1.3. Mexico Neurosurgery Devices Market Size in USD million (2023-2034)
  • 7.4.2. Europe
    • 7.4.2.1. France Neurosurgery Devices Market Size in USD million (2023-2034)
    • 7.4.2.2. Germany Neurosurgery Devices Market Size in USD million (2023-2034)
    • 7.4.2.3. United Kingdom Neurosurgery Devices Market Size in USD million (2023-2034)
    • 7.4.2.4. Italy Neurosurgery Devices Market Size in USD million (2023-2034)
    • 7.4.2.5. Spain Neurosurgery Devices Market Size in USD million (2023-2034)
    • 7.4.2.6. Rest of Europe Neurosurgery Devices Market Size in USD million (2023-2034)
  • 7.4.3. Asia-Pacific
    • 7.4.3.1. China Neurosurgery Devices Market Size in USD million (2023-2034)
    • 7.4.3.2. Japan Neurosurgery Devices Market Size in USD million (2023-2034)
    • 7.4.3.3. India Neurosurgery Devices Market Size in USD million (2023-2034)
    • 7.4.3.4. Australia Neurosurgery Devices Market Size in USD million (2023-2034)
    • 7.4.3.5. South Korea Neurosurgery Devices Market Size in USD million (2023-2034)
    • 7.4.3.6. Rest of Asia-Pacific Neurosurgery Devices Market Size in USD million (2023-2034)
  • 7.4.4. Rest of the World
    • 7.4.4.1. Middle East Neurosurgery Devices Market Size in USD million (2023-2034)
    • 7.4.4.2. Africa Neurosurgery Devices Market Size in USD million (2023-2034)
    • 7.4.4.3. South America Neurosurgery Devices Market Size in USD million (2023-2034)

8. Neurosurgery Devices Market Competitive Landscape

• 8.1. Competitive Analysis
• 8.2. Company Share Analysis (Premium Offering)

9. Neurosurgery Devices Market Startup Funding and Investment Trends

10. Neurosurgery Devices Market Company and Product Profiles

• 10.1. Medtronic plc
  • 10.1.1. Company Overview
  • 10.1.2. Company Snapshot
  • 10.1.3. Financial Overview
  • 10.1.4. Product Listing
  • 10.1.5. Strategic Initiatives / Entropy
• 10.2. Stryker Corporation
  • 10.2.1. Company Overview
  • 10.2.2. Company Snapshot
  • 10.2.3. Financial Overview
  • 10.2.4. Product Listing
  • 10.2.5. Strategic Initiatives / Entropy
• 10.3. Integra LifeSciences Holdings Corporation
  • 10.3.1. Company Overview
  • 10.3.2. Company Snapshot
  • 10.3.3. Financial Overview
  • 10.3.4. Product Listing
  • 10.3.5. Strategic Initiatives / Entropy
• 10.4. B. Braun SE (Aesculap)
  • 10.4.1. Company Overview
  • 10.4.2. Company Snapshot
  • 10.4.3. Financial Overview
  • 10.4.4. Product Listing
  • 10.4.5. Strategic Initiatives / Entropy
• 10.5. Johnson & Johnson MedTech (DePuy Synthes)
  • 10.5.1. Company Overview
  • 10.5.2. Company Snapshot
  • 10.5.3. Financial Overview
  • 10.5.4. Product Listing
  • 10.5.5. Strategic Initiatives / Entropy
• 10.6. Zimmer Biomet Holdings Inc.
  • 10.6.1. Company Overview
  • 10.6.2. Company Snapshot
  • 10.6.3. Financial Overview
  • 10.6.4. Product Listing
  • 10.6.5. Strategic Initiatives / Entropy
• 10.7. Brainlab AG
  • 10.7.1. Company Overview
  • 10.7.2. Company Snapshot
  • 10.7.3. Financial Overview
  • 10.7.4. Product Listing
  • 10.7.5. Strategic Initiatives / Entropy
• 10.8. KARL STORZ SE & Co. KG
  • 10.8.1. Company Overview
  • 10.8.2. Company Snapshot
  • 10.8.3. Financial Overview
  • 10.8.4. Product Listing
  • 10.8.5. Strategic Initiatives / Entropy
• 10.9. Elekta AB
  • 10.9.1. Company Overview
  • 10.9.2. Company Snapshot
  • 10.9.3. Financial Overview
  • 10.9.4. Product Listing
  • 10.9.5. Strategic Initiatives / Entropy
• 10.10. Globus Medical Inc.
  • 10.10.1. Company Overview
  • 10.10.2. Company Snapshot
  • 10.10.3. Financial Overview
  • 10.10.4. Product Listing
  • 10.10.5. Strategic Initiatives / Entropy

11. KOL Views

12. Project Approach

13. About DelveInsight

14. Disclaimer and Contact Us